Literature DB >> 29692186

Outcome of indeterminate liver lesions on computed tomography in patients with colorectal cancer.

E Mohamed1, A Adiamah1, W K Dunn1, Y Higashi1, I C Cameron1, D Gomez1.   

Abstract

Introduction The aim of this study was to determinate the outcome of indeterminate liver lesions on computed tomography (CT) in patients with a background history of colorectal cancer (CRC) and to identify clinicopathological variables associated with malignancy in these lesions. A secondary aim was to devise a management algorithm for such patients. Methods Patients referred to our institution with indeterminate liver lesions on CT with a background history of CRC between January 2012 and December 2014 were included in the study. Clinicopathological factors, surveillance period and histological findings were analysed. Results Fifty-six patients with indeterminate liver lesions were identified. Fifty-three (94.6%) of these required further imaging (magnetic resonance imaging [MRI; n=50] and positron emission tomography combined with CT [n=3]). For the patients who had MRI, the underlying diagnosis was benign in 19 and colorectal liver metastasis (CRLM) in 8 while 23 patients and an indeterminate lesion. In cases that remained indeterminate following MRI, liver resection was performed in 2 patients for a high suspicion of CRLM while the 21 remaining patients underwent interval surveillance (median: 9 months, range: 3-52 months). Of these 21 patients, 14 had benign lesions while CRLM was noted in 6 patients and an incidental hepatocellular carcinoma in a single patient. Age ≥65 years was the only statistically significant clinicopathological factor in predicting an underlying malignancy in patients with indeterminate liver lesions on CT. Conclusions Over a third of the patients diagnosed with indeterminate liver lesions on CT subsequently showed evidence of CRLM. These indeterminate lesions are more likely to be malignant in patients aged ≥65 years.

Entities:  

Keywords:  Chemotherapy; Colorectal liver metastases; Liver resection

Mesh:

Year:  2018        PMID: 29692186      PMCID: PMC5956611          DOI: 10.1308/rcsann.2018.0070

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  27 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

3.  Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.

Authors:  Kyriakos Neofytou; Elizabeth C Smyth; Alexandros Giakoustidis; Aamir Z Khan; David Cunningham; Satvinder Mudan
Journal:  Med Oncol       Date:  2014-09-14       Impact factor: 3.064

Review 4.  The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.

Authors:  Bastiaan Wiering; Paul F M Krabbe; Gerrit J Jager; Wim J G Oyen; Theo J M Ruers
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

5.  A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?

Authors:  Adrian B Cresswell; Fenella K S Welsh; Myrddin Rees
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

6.  Prevalence and importance of small hepatic lesions found at CT in patients with cancer.

Authors:  L H Schwartz; E J Gandras; S M Colangelo; M C Ercolani; D M Panicek
Journal:  Radiology       Date:  1999-01       Impact factor: 11.105

7.  MRI of Focal Liver Lesions.

Authors:  Nils Albiin
Journal:  Curr Med Imaging Rev       Date:  2012-05

8.  Resection margin influences the outcome of patients with bilobar colorectal liver metastases.

Authors:  Sara Di Carlo; Derek Yeung; Jamie Mills; Abed Zaitoun; Iain Cameron; Dhanny Gomez
Journal:  World J Hepatol       Date:  2016-12-08

9.  Impact of steatosis on perioperative outcome following hepatic resection.

Authors:  David A Kooby; Yuman Fong; Arief Suriawinata; Mithat Gonen; Peter J Allen; David S Klimstra; Ronald P DeMatteo; Michael D'Angelica; Leslie H Blumgart; William R Jarnagin
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

10.  Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.

Authors:  C J Zech; P Korpraphong; A Huppertz; T Denecke; M J Kim; W Tanomkiat; E Jonas; A Ba-Ssalamah
Journal:  Br J Surg       Date:  2014-03-20       Impact factor: 6.939

View more
  3 in total

1.  Newly detected liver nodules with a history of colorectal cancer: are they metastatic? Review of 2,632 cases in a single center.

Authors:  Kai Zhu; Wentao Wang; Rongkui Luo; Danjun Song; Xi Wang; Qiang Gao; Jia Fan; Jian Zhou; Shengxiang Rao; Xiaoying Wang
Journal:  Ann Transl Med       Date:  2021-07

2.  Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastases.

Authors:  Thomas Reinert; Lena Marie Skindhøj Petersen; Tenna Vesterman Henriksen; Marie Øbo Larsen; Mads Heilskov Rasmussen; Amanda Frydendahl Boll Johansen; Nadia Øgaard; Michael Knudsen; Iver Nordentoft; Søren Vang; Søren Rasmus Palmelund Krag; Anders Riegels Knudsen; Frank Viborg Mortensen; Claus Lindbjerg Andersen
Journal:  Int J Cancer       Date:  2022-01-19       Impact factor: 7.316

3.  Pitfalls and value of organ specific approach in evaluating indeterminate lesions detected on CT in colorectal cancer by [F18] FDG PET/CT.

Authors:  Wael M Marashdeh; Kusai M Al-Mugbel; Mohanad Mutasem Alebbini; Amr Ghassan Tashtoush; Ahmad Abdalmajeed Alghzawi; Ma'moon H Al-Omari; Osama M Alshari
Journal:  Eur J Radiol Open       Date:  2020-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.